#Can­nes­Lions2022: Phar­ma cre­ativ­i­ty awards shine spot­light on Hori­zon, Evofem and Ab­bott

3 years ago
Pharma
Marketing

Lat­est news on thumbs down for Nu­plazid; Amy­lyx’s first ALS ap­proval; Buy­out buzz for trou­bled biotechs; Cannes ...

3 years ago
Weekly

FDA ad­vi­sors most­ly agree that Aca­dia’s Nu­plazid is­n't ef­fec­tive at treat­ing Alzheimer’s-re­lat­ed psy­chosis

3 years ago
FDA+

WTO's IP waiv­er for vac­cines is out and the re­sponse is gen­er­al­ly neg­a­tive — from all sides

3 years ago
Pharma
Coronavirus

Tee­ter­ing on the brink, Clo­vis aban­dons an ear­ly ap­proval for Rubra­ca

3 years ago
R&D

Bris­tol My­ers pe­ti­tions the Supreme Court in a fi­nal bid to prove Gilead­'s Kite in­fringed on CAR-T patents

3 years ago
Law

Push­ing for top spot in Big Phar­ma, Ab­b­Vie lands a key ap­proval for its block­buster Skyrizi

3 years ago
Pharma
FDA+

Gal­der­ma kicks off aes­thet­ics brand cam­paign at New York City Pride­Fest

3 years ago
Pharma
Marketing

J&J inks clin­i­cal tri­al deal with Stand Up To Can­cer, lat­est phar­ma to join can­cer non­prof­it study ef­forts

3 years ago
Pharma
Marketing

Rhythm gets sec­ond OK for ge­net­ic obe­si­ty drug Im­civree, swings in­to roy­al­ty deal

3 years ago
Deals
Pharma

Up­dat­ed: Mer­ck look­ing at Seagen takeover bid in the wake of Clay Sie­gal­l's res­ig­na­tion — re­port

3 years ago
Deals
Pharma

In at­tempt­ed bear mar­ket brush­back, SMA play­er Schol­ar Rock nabs $205M raise on open-la­bel ex­ten­sion da­ta

3 years ago
Financing
R&D

FDA au­tho­rizes Pfiz­er, Mod­er­na Covid-19 vac­cines for chil­dren as young as 6 months

3 years ago
Pharma
FDA+

SPAC deal touch­es down for mi­cro­cap biotech armed with a PhII, for­mer Pfiz­er mon­o­clon­al an­ti­body

3 years ago
Financing

Glob­al health of­fi­cials are search­ing for a new name for mon­key­pox as sci­en­tists warn against stig­ma­tiz­ing the virus

3 years ago
Pharma

Boehringer In­gel­heim to in­cu­bate biotechs with Hong Kong R&D leader

3 years ago
Startups
China

Buy­out buzz: Is As­traZeneca hunt­ing a mi­cro-M&A deal on Nas­daq?

3 years ago
Deals

As law­suit car­ries on against Guardant Health, CFO shake­up hits Il­lu­mi­na; Pfiz­er-backed biotech taps CEO to lead ...

3 years ago
Peer Review

FTC tar­gets in­sulin, threat­en­ing to go af­ter PBM-phar­ma deals that steer in­to 'com­mer­cial bribery'

3 years ago
Pharma

As Covid-re­lat­ed chal­lenges weigh on pa­tient re­cruit­ment, biotech scraps PhI­Ib/III Parkin­son's pro­gram

3 years ago
R&D

New kid on the block: Roger Perl­mut­ter's biotech signs on as an­chor ten­ant to new Bay Area cam­pus

3 years ago
Startups

Abu Dhabi's health de­part­ment taps Sanofi in clin­i­cal re­search and AI screen­ing deal

3 years ago
Deals
Pharma

Reg­u­lat­ing new re­gen­er­a­tive ther­a­pies: FDA kicks off the process of rec­og­niz­ing vol­un­tary stan­dards

3 years ago
Cell/Gene Tx
FDA+

Men­tal health cri­sis fol­lows Covid pan­dem­ic in US, but phar­ma miss­ing con­nec­tions to younger gen­er­a­tions, study finds

3 years ago
Pharma
Marketing
First page Previous page 511512513514515516517 Next page Last page
A service from the Financial Times